RNAimmune

RNAimmune is a leading company in the field of messenger RNA (mRNA) technology, with over 20 years of expertise in handling and optimizing this versatile molecule for medical purposes. The principle behind RNAimmune's proprietary technology is to use mRNA as a data carrier to instruct the human body to produce its own proteins capable of resisting various diseases. The company applies its technology to cancer therapies, antibody therapies, treatments for rare diseases, and the development of preventive vaccines. It has developed an artificial intelligence-assisted platform based on synthetic biology that helps design superior mRNA to elicit optimal immune system responses. Current projects supported by this platform include multi-target preventive vaccines expressing tumor-targeting epitopes and cancer vaccines. The company also develops therapeutic vaccines based on individual neoantigens for cancer treatment and provides early detection and companion diagnostics.